229 related articles for article (PubMed ID: 24036385)
1. Cardiac magnetic resonance postcontrast T1 time is associated with outcome in patients with heart failure and preserved ejection fraction.
Mascherbauer J; Marzluf BA; Tufaro C; Pfaffenberger S; Graf A; Wexberg P; Panzenböck A; Jakowitsch J; Bangert C; Laimer D; Schreiber C; Karakus G; Hülsmann M; Pacher R; Lang IM; Maurer G; Bonderman D
Circ Cardiovasc Imaging; 2013 Nov; 6(6):1056-65. PubMed ID: 24036385
[TBL] [Abstract][Full Text] [Related]
2. Diffuse right ventricular fibrosis in heart failure with preserved ejection fraction and pulmonary hypertension.
Patel RB; Li E; Benefield BC; Swat SA; Polsinelli VB; Carr JC; Shah SJ; Markl M; Collins JD; Freed BH
ESC Heart Fail; 2020 Feb; 7(1):253-263. PubMed ID: 31903694
[TBL] [Abstract][Full Text] [Related]
3. Relationship Between Focal and Diffuse Fibrosis Assessed by CMR and Clinical Outcomes in Heart Failure With Preserved Ejection Fraction.
Kanagala P; Cheng ASH; Singh A; Khan JN; Gulsin GS; Patel P; Gupta P; Arnold JR; Squire IB; Ng LL; McCann GP
JACC Cardiovasc Imaging; 2019 Nov; 12(11 Pt 2):2291-2301. PubMed ID: 30772227
[TBL] [Abstract][Full Text] [Related]
4. Interstitial Fibrosis, Functional Status, and Outcomes in Heart Failure With Preserved Ejection Fraction: Insights From a Prospective Cardiac Magnetic Resonance Imaging Study.
Duca F; Kammerlander AA; Zotter-Tufaro C; Aschauer S; Schwaiger ML; Marzluf BA; Bonderman D; Mascherbauer J
Circ Cardiovasc Imaging; 2016 Dec; 9(12):. PubMed ID: 27974408
[TBL] [Abstract][Full Text] [Related]
5. Extracellular Volume Fraction for Characterization of Patients With Heart Failure and Preserved Ejection Fraction.
Rommel KP; von Roeder M; Latuscynski K; Oberueck C; Blazek S; Fengler K; Besler C; Sandri M; Lücke C; Gutberlet M; Linke A; Schuler G; Lurz P
J Am Coll Cardiol; 2016 Apr; 67(15):1815-1825. PubMed ID: 27081022
[TBL] [Abstract][Full Text] [Related]
6. The right heart in heart failure with preserved ejection fraction: insights from cardiac magnetic resonance imaging and invasive haemodynamics.
Aschauer S; Kammerlander AA; Zotter-Tufaro C; Ristl R; Pfaffenberger S; Bachmann A; Duca F; Marzluf BA; Bonderman D; Mascherbauer J
Eur J Heart Fail; 2016 Jan; 18(1):71-80. PubMed ID: 26449727
[TBL] [Abstract][Full Text] [Related]
7. Outcome in Heart Failure with Preserved Ejection Fraction: The Role of Myocardial Structure and Right Ventricular Performance.
Goliasch G; Zotter-Tufaro C; Aschauer S; Duca F; Koell B; Kammerlander AA; Ristl R; Lang IM; Maurer G; Mascherbauer J; Bonderman D
PLoS One; 2015; 10(7):e0134479. PubMed ID: 26225557
[TBL] [Abstract][Full Text] [Related]
8. Effects of vasodilation in heart failure with preserved or reduced ejection fraction implications of distinct pathophysiologies on response to therapy.
Schwartzenberg S; Redfield MM; From AM; Sorajja P; Nishimura RA; Borlaug BA
J Am Coll Cardiol; 2012 Jan; 59(5):442-51. PubMed ID: 22281246
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of quantitative assessment of focal myocardial fibrosis in patients with heart failure with preserved ejection fraction.
Kato S; Saito N; Kirigaya H; Gyotoku D; Iinuma N; Kusakawa Y; Iguchi K; Nakachi T; Fukui K; Futaki M; Iwasawa T; Taguri M; Kimura K; Umemura S
Int J Cardiol; 2015 Jul; 191():314-9. PubMed ID: 26005800
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of pulmonary vascular resistance estimated by cardiac magnetic resonance in patients with chronic heart failure.
Fabregat-Andrés Ó; Estornell-Erill J; Ridocci-Soriano F; García-González P; Bochard-Villanueva B; Cubillos-Arango A; Espriella-Juan Rde L; Fácila L; Morell S; Cortijo J
Eur Heart J Cardiovasc Imaging; 2014 Dec; 15(12):1391-9. PubMed ID: 25104808
[TBL] [Abstract][Full Text] [Related]
11. Value of early cardiovascular magnetic resonance for the prediction of adverse arrhythmic cardiac events after a first noncomplicated ST-segment-elevation myocardial infarction.
Izquierdo M; Ruiz-Granell R; Bonanad C; Chaustre F; Gomez C; Ferrero A; Lopez-Lereu P; Monmeneu JV; Nuñez J; Chorro FJ; Bodi V
Circ Cardiovasc Imaging; 2013 Sep; 6(5):755-61. PubMed ID: 23926195
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive Echocardiographic and Cardiac Magnetic Resonance Evaluation Differentiates Among Heart Failure With Preserved Ejection Fraction Patients, Hypertensive Patients, and Healthy Control Subjects.
Mordi IR; Singh S; Rudd A; Srinivasan J; Frenneaux M; Tzemos N; Dawson DK
JACC Cardiovasc Imaging; 2018 Apr; 11(4):577-585. PubMed ID: 28823736
[TBL] [Abstract][Full Text] [Related]
13. Letter by Barison et al regarding article, "Cardiac magnetic resonance postcontrast T1 time is associated with outcome in patients with heart failure and preserved ejection fraction".
Barison A; Aquaro GD; Masci PG
Circ Cardiovasc Imaging; 2014 Mar; 7(2):414. PubMed ID: 24642926
[No Abstract] [Full Text] [Related]
14. Growth differentiation factor-15 is a useful prognostic marker in patients with heart failure with preserved ejection fraction.
Izumiya Y; Hanatani S; Kimura Y; Takashio S; Yamamoto E; Kusaka H; Tokitsu T; Rokutanda T; Araki S; Tsujita K; Tanaka T; Yamamuro M; Kojima S; Tayama S; Kaikita K; Hokimoto S; Ogawa H
Can J Cardiol; 2014 Mar; 30(3):338-44. PubMed ID: 24484911
[TBL] [Abstract][Full Text] [Related]
15. Epicardial fat in heart failure patients with mid-range and preserved ejection fraction.
van Woerden G; Gorter TM; Westenbrink BD; Willems TP; van Veldhuisen DJ; Rienstra M
Eur J Heart Fail; 2018 Nov; 20(11):1559-1566. PubMed ID: 30070041
[TBL] [Abstract][Full Text] [Related]
16. Quantification of myocardial iron deficiency in nonischemic heart failure by cardiac T2* magnetic resonance imaging.
Nagao M; Matsuo Y; Kamitani T; Yonezawa M; Yamasaki Y; Kawanami S; Abe K; Mukai Y; Higo T; Yabuuchi H; Takemura A; Yoshiura T; Sunagawa K; Honda H
Am J Cardiol; 2014 Mar; 113(6):1024-30. PubMed ID: 24461766
[TBL] [Abstract][Full Text] [Related]
17. Use of quantitative analysis of remote myocardial fibrosis with delayed-enhancement magnetic resonance imaging to predict outcomes after surgical ventricular restoration for ischemic cardiomyopathy.
Takeda K; Matsumiya G; Matsue H; Hamada S; Sakaki M; Sakaguchi T; Fujita T; Sawa Y
J Thorac Cardiovasc Surg; 2008 Dec; 136(6):1514-21. PubMed ID: 19114200
[TBL] [Abstract][Full Text] [Related]
18. Native T1 time of right ventricular insertion points by cardiac magnetic resonance: relation with invasive haemodynamics and outcome in heart failure with preserved ejection fraction.
Nitsche C; Kammerlander AA; Binder C; Duca F; Aschauer S; Koschutnik M; Snidat A; Beitzke D; Loewe C; Bonderman D; Hengstenberg C; Mascherbauer J
Eur Heart J Cardiovasc Imaging; 2020 Jun; 21(6):683-691. PubMed ID: 31495874
[TBL] [Abstract][Full Text] [Related]
19. Differential impact of heart rate and blood pressure on outcome in patients with heart failure with reduced versus preserved left ventricular ejection fraction.
Maeder MT; Kaye DM
Int J Cardiol; 2012 Mar; 155(2):249-56. PubMed ID: 21035207
[TBL] [Abstract][Full Text] [Related]
20. Implications of coronary artery disease in heart failure with preserved ejection fraction.
Hwang SJ; Melenovsky V; Borlaug BA
J Am Coll Cardiol; 2014 Jul; 63(25 Pt A):2817-27. PubMed ID: 24768876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
